Mounjaro serious side effects: what they are and when to act

Acute pancreatitis is a known, infrequent but potentially serious risk with GLP-1 and dual-agonist medicines — the MHRA issued a formal Drug Safety Update on this in January 2026.
Severe stomach pain spreading to the back, signs of a serious allergic reaction, or significant gallbladder symptoms all require urgent medical attention, not a wait-and-see approach.
Most common side effects (nausea, loose stools, indigestion) are not serious, but severe or prolonged vomiting can lead to dehydration, which is a secondary risk worth monitoring.
Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

The serious side effects of Mounjaro (tirzepatide) are uncommon but real, and knowing the warning signs matters. Most people on treatment experience mild, short-lived nausea or digestive discomfort — but a small number encounter something more urgent. Mounjaro is a prescription-only medicine; a clinician assesses your full medical history before any prescription is issued, specifically to weigh these risks against your individual circumstances. This page covers what the serious side effects are, how to recognise them, and what to do if they arise.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The serious side effects of Mounjaro in detail, and how to respond to each

What makes a Mounjaro side effect 'serious' rather than just uncomfortable?

There's a common assumption that all the side effects of tirzepatide are gastric, a few days of queasiness and then fine. That picture is mostly accurate for the majority of people, but it misses the smaller category of reactions that need prompt clinical attention rather than patience.

Clinicians distinguish between common and expected effects (nausea, constipation, loose stools, burping, indigestion, fatigue, headache) and serious effects, those that are rarer, potentially harmful, and require action. The NHS patient information for tirzepatide outlines both categories; the more detailed breakdown, including frequencies, is in the Mounjaro SmPC on the eMC.

Seriousness isn't just about intensity. A side effect qualifies as serious when it carries a risk of significant harm, requires hospitalisation, or could worsen rapidly without treatment. For tirzepatide specifically, the major ones are: acute pancreatitis, gallbladder disease, severe allergic reactions, kidney injury secondary to dehydration, and (in people with a history of diabetic eye disease) worsening retinopathy. Understanding the broader picture of Mounjaro's side effects helps to put the serious ones in context, and if you want a focused overview, our page covering the five most commonly reported Mounjaro side effects is a useful starting point.

None of this should be read as a reason to avoid treatment if you're clinically suitable. It is a reason to know what you're watching for.

Which serious Mounjaro side effects should prompt a call to 111 or an emergency visit?

Pancreatitis is the one clinicians think about most carefully. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent risk across GLP-1 medicines. The symptom to act on immediately is severe, persistent stomach pain, particularly pain that radiates through to the back, with or without vomiting. This is not ordinary nausea. It tends to be constant rather than cramping, and it does not settle with rest. If that description fits, seek urgent medical help. Do not treat it as a standard digestive side effect.

Gallbladder problems (including gallstones and inflammation of the gallbladder (cholecystitis)) are also listed in the Mounjaro safety data. Watch for sharp pain in the upper right abdomen, particularly after eating, or pain radiating to the right shoulder. Fever and yellowing of the skin or eyes alongside abdominal pain are additional signals.

Serious allergic reactions are rare but possible. Signs include swelling of the face, lips, tongue or throat, difficulty breathing, or a widespread rash developing quickly after injection. This is a 999 situation. A milder localised reaction at the injection site (redness, itching) is much more common and far less concerning, but if swelling spreads or breathing is affected, do not wait.

Kidney problems can develop as a consequence of severe fluid loss from prolonged vomiting or diarrhoea. If you become unable to keep fluids down for more than a day, or notice significantly reduced urination, get medical advice. It is also worth knowing that some people experience particular side effects depending on how their body responds to Mounjaro, which can help you judge whether what you're feeling is typical or warrants closer attention. You can read about managing nausea alongside Mounjaro for practical steps that may reduce the risk of reaching that point.

Are there serious side effects specific to certain groups of people?

Yes, and this is one reason the prescribing assessment asks about your medical history in some detail.

People with a personal or family history of medullary thyroid carcinoma (a specific type of thyroid cancer) or a condition called Multiple Endocrine Neoplasia type 2 (MEN2) should not take tirzepatide. This restriction comes from animal studies showing thyroid tumours at high doses; while the human relevance of this finding is not established with certainty, the contraindication is included in the licence and the SmPC.

Pancreatitis history is also a factor. If you've had pancreatitis before, the prescriber will weigh that carefully, it is not an automatic bar in all cases, but it is a conversation that must happen.

For people with diabetic retinopathy, rapid improvement in blood sugar control can, paradoxically, temporarily worsen eye disease. This is relevant mainly in people using tirzepatide to manage type 2 diabetes, but it is worth mentioning to your prescriber if you have a history of diabetic eye disease.

If you are pregnant, breastfeeding, or actively trying to conceive, tirzepatide is not recommended. Women of childbearing age using oral contraceptives should add a non-oral method for the first four weeks of treatment and for four weeks after any dose increase, as tirzepatide can affect pill absorption. Some people also find reassurance in reading about what it looks like when Mounjaro causes no side effects, as individual responses genuinely vary. Hormonal and cycle-related effects are a separate but connected topic worth reviewing. Our clinical team (including our lead prescriber) goes through all of this at consultation.

How do you report a serious side effect, and what happens if you're a nume patient?

Any suspected serious side effect from a medicine can be reported to the MHRA via the Yellow Card scheme. This applies to anyone (patient, carer, or clinician) and the information genuinely feeds into national safety monitoring. You don't need to be certain it's caused by the medicine to report it. Suspected links count.

If you're being treated through a regulated pharmacy such as ours, your prescriber is your first point of clinical contact for questions about reactions. nume provides priority aftercare seven days a week, if something doesn't feel right, getting in touch directly is always the right call. We'd rather hear from you than have you second-guessing a symptom alone.

For broader questions about whether tirzepatide is appropriate for your situation (or if you've read this page and want to understand how your specific history would be assessed) a free consultation with our prescribers is the place to start. They discuss suitability, including side effects, as a standard part of every review. You can also explore the service FAQs or contact the team directly with a question before you start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions